glp-1 obesity drug news A network meta-analysis backed weight-loss benefits with several receptor agonists, with less certainty for newer-generation agents. Read more at the link in bio glp-1 obesity drug news today
Description
[DOI] [PMC free article] [PubMed] [Google Scholar] 149.El K, Douros JD, Willard FS, et al
E.AhreB
It does not bind to specific receptors or trigger direct hormonal responses in the manner of medications
The current BMI, the realistic medical target, and how much of the goal is about magnitude versus sustainability
Last revision December 15, 2024
95% CI 0.85, 0.94) and composite cerebrovascular events (HR 0.93
